Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency

Stock Information for Jaguar Health Inc.

Loading

Please wait while we load your information from QuoteMedia.